PCT/2001/21 : PCT Gazette, Weekly Issue No. 21, 2001 - WIPO
PCT/2001/21 : PCT Gazette, Weekly Issue No. 21, 2001 - WIPO
PCT/2001/21 : PCT Gazette, Weekly Issue No. 21, 2001 - WIPO
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>21</strong>/<strong>2001</strong><br />
25 May/mai <strong>2001</strong> <strong>PCT</strong> <strong>Gazette</strong> - Section I - <strong>Gazette</strong> du <strong>PCT</strong> 8613<br />
(74) DICKSON, Elizabeth, Anne; Reckitt<br />
Benckiser plc, Group Patents Dept., Dansom<br />
Lane, Hull HU8 7DS (GB).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CR CU CZ DE DK DM<br />
DZ EE ES FI GB GD GE GH GM HR HU<br />
ID IL IN IS JP KE KG KP KR KZ LC LK<br />
LR LS LT LU LV MA MD MG MK MN MW<br />
MX MZ NO NZ PL PT RO RU SD SE SG SI<br />
SK SL TJ TM TR TT TZ UA UG US UZ VN<br />
YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GW ML MR<br />
NE SN TD TG).<br />
(51) 7 A61K 31/00<br />
(11) WO 01/35943 (13) A2<br />
(<strong>21</strong>) <strong>PCT</strong>/IN00/00110<br />
(22) 10 <strong>No</strong>v/nov 2000 (10.11.2000)<br />
(25) en (26) en<br />
(30) 1106/MAS/99 15 <strong>No</strong>v/nov 1999 IN<br />
(15.11.1999)<br />
(43) 25 May/mai <strong>2001</strong> (25.05.<strong>2001</strong>)<br />
(54) DEXTROSE AND INSULIN FLUID<br />
FORMULATION FOR INTRAVENOUS<br />
INFUSION<br />
PREPARATION DE FLUIDES A BASE<br />
DE DEXTROSE ET D’INSULINE DES-<br />
TINEE A UNE INFUSION INTRAVEI-<br />
NEUSE<br />
(71, 72) GANGAL, Hanamaraddi, T. [IN/IN];<br />
P.B. Road & 3nd cross, Hosur, Hubli 580 0<strong>21</strong>,<br />
Karnataka (IN).<br />
(72, 75) GANGAL, Parag, H. [IN/IN]; P.B. Road<br />
& 3nd cross, Hosur, Hubli 580 0<strong>21</strong>, Karnataka<br />
(IN). GANGAL, Madhumati, H. [IN/IN];<br />
P.B. Road & 3nd cross, Hosur, Hubli 580 0<strong>21</strong>,<br />
Karnataka (IN).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CR CU CZ DE DK DM<br />
DZ EE ES FI GB GD GE GH GM HR HU<br />
ID IL IN IS JP KE KG KP KR KZ LC LK<br />
LR LS LT LU LV MA MD MG MK MN MW<br />
MX MZ NO NZ PL PT RO RU SD SE SG SI<br />
SK SL TJ TM TR TT TZ UA UG US UZ VN<br />
YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GW ML MR<br />
NE SN TD TG).<br />
(51) 7 A61K 31/00<br />
(11) WO 01/35944<br />
(<strong>21</strong>) <strong>PCT</strong>/IT00/00462<br />
(13) A2<br />
(22) 14 <strong>No</strong>v/nov 2000 (14.11.2000)<br />
(25) en (26) en<br />
(30) RM99A000707 18 <strong>No</strong>v/nov 1999<br />
(18.11.1999)<br />
IT<br />
(43) 25 May/mai <strong>2001</strong> (25.05.<strong>2001</strong>)<br />
(54) COMPOSITION FOR THE PREVEN-<br />
TION AND/OR TREATMENT OF DIS-<br />
ORDERS DUE TO ABNORMAL LIPID<br />
METABOLISM, COMPRISING PROPI-<br />
ONYL L-CARNITINE AND CHITOSAN<br />
COMPOSITION UTILISEE DANS LA<br />
PREVENTION ET/OU LE TRAITE-<br />
MENT DE TROUBLES DUS A UN ME-<br />
TABOLISME LIPIDIQUE ANORMAL,<br />
COMPRENANT DE LA L-CARNITINE<br />
ET DU CHITOSANE<br />
(71) SIGMA-TAU HEALTHSCIENCE S.P.A.<br />
[IT/IT]; Via Treviso, 4, I-00040 Pomezia<br />
(IT).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) CAVAZZA, Claudio [IT/IT]; Piazza<br />
Campitelli, 2, I-00186 Roma (IT).<br />
(74) CAVATTONI, Fabio et al. / etc.; Cavattoni<br />
- Raimondi, Viale dei Parioli, 160, I-00197<br />
Roma (IT).<br />
(81) AE AL AM AT AU AZ BA BB BG BR BY<br />
CA CH CN CR CU CZ DE DK DM DZ EE<br />
ES FI GB GD GE GH GM HR HU ID IL IN<br />
IS JP KE KG KP KR KZ LC LK LR LS LT<br />
LU LV MA MD MG MK MN MW MX NO<br />
NZ PL PT RO RU SD SE SG SI SK SL TJ TM<br />
TR TT TZ UA UG US UZ VN YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GW ML MR<br />
NE SN TD TG).<br />
(51) 7 A61K 31/00<br />
(11) WO 01/35945<br />
(<strong>21</strong>) <strong>PCT</strong>/SG00/00191<br />
(13) A2<br />
(22) 16 <strong>No</strong>v/nov 2000 (16.11.2000)<br />
(25) en (26) en<br />
(30) 9905846-3 18 <strong>No</strong>v/nov 1999<br />
(18.11.1999)<br />
SG<br />
(43) 25 May/mai <strong>2001</strong> (25.05.<strong>2001</strong>)<br />
(54) A METHOD OF TREATMENT AND<br />
PROPHYLAXIS<br />
METHODE THERAPEUTIQUE ET<br />
PROPHYLACTIQUE<br />
(71) THE NATIONAL UNIVERSITY OF SIN-<br />
GAPORE [SG/SG]; 10 Kent Ridge Crescent,<br />
Singapore 119260 (SG).<br />
(72) ADAIKAN, s/o Periannan; 11 The Inglewood,<br />
Singapore 575040 (SG). NG, Soon,<br />
Chye; 177D, Hillcrest Road, Singapore<br />
289057 (SG).<br />
(74) NAMAZIE, Mirza, Khaleel; Tan Rajah &<br />
Cheah, 9 Battery Road #15-00, Straits Trading<br />
Building, Singapore 049910 (SG).<br />
(81) DE GB JP.<br />
(84) EP (AT BE CH CY DE DK ES FI FR GB GR<br />
IE IT LU MC NL PT SE TR).<br />
(51) 7 A61K 31/00<br />
(11) WO 01/35946<br />
(<strong>21</strong>) <strong>PCT</strong>/US00/27394<br />
(13) A2<br />
(22) 5 Oct/oct 2000 (05.10.2000)<br />
(25) en (26) en<br />
(30) 60/164,965 15 <strong>No</strong>v/nov 1999<br />
(15.11.1999)<br />
US<br />
(43) 25 May/mai <strong>2001</strong> (25.05.<strong>2001</strong>)<br />
(54) INTRANASAL ADMINISTRATION OF<br />
RALOXIFENE AND TAMOXIFEN<br />
ADMINISTRATION INTRANASALE<br />
DE RALOXIFENE ET DE TAMOXI-<br />
FENE<br />
(71) NEW MILLENNIUM PHARMACEUTI-<br />
CAL RESEARCH, INC. [US/US]; University<br />
of Kentucky, A-345 ASTeCC Facility,<br />
Lexington, KY 40506-0286 (US).<br />
(72) HUSSAIN, Anwar, A.; 886 McMeekin<br />
Place, Lexington, KY 40502 (US). DIT-<br />
TERT, Lewis, W.; 4999 Hartland Parkway,<br />
Lexington, KY 40515 (US).<br />
(74) REA, Teresa, Stanek et al. / etc.; Burns,<br />
Doane, Swecker and Mathis, L.L.P., P.O. Box<br />
1404, Alexandria, VA 22313-1404 (US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CR CU CZ DE DK DM<br />
DZ EE ES FI GB GD GE GH GM HR HU<br />
ID IL IN IS JP KE KG KP KR KZ LC LK<br />
LR LS LT LU LV MA MD MG MK MN MW<br />
MX MZ NO NZ PL PT RO RU SD SE SG SI<br />
SK SL TJ TM TR TT TZ UA UG UZ VN YU<br />
ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI FR<br />
GB GR IE IT LU MC NL PT SE); OA (BF BJ<br />
CF CG CI CM GA GN GW ML MR NE SN<br />
TD TG).<br />
(51) 7 A61K 31/00<br />
(11) WO 01/35947<br />
(<strong>21</strong>) <strong>PCT</strong>/US00/28889<br />
(13) A2<br />
(22) 13 <strong>No</strong>v/nov 2000 (13.11.2000)<br />
(25) en (26) en<br />
(30) 60/165,464 15 <strong>No</strong>v/nov 1999<br />
(15.11.1999)<br />
US<br />
(43) 25 May/mai <strong>2001</strong> (25.05.<strong>2001</strong>)<br />
(54) TREATING WASTING SYNDROMES<br />
WITH ARYLOXY PROPANOLAMINES<br />
TRAITEMENT DES SYNDROMES CA-<br />
CHECTIQUES AU MOYEN DE PROPA-<br />
NOLAMINES ARYLOXY<br />
(71) ELI LILLY AND COMPANY [US/US];<br />
Lilly Corporate Center,<br />
46285 (US).<br />
Indianapolis, IN<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) HANCOCK, Deana, Lori [US/US];<br />
8672 East 450 South, Carthage, IN 46115<br />
(US). HOPKINS, Randall, Bruce [US/US];<br />
956 <strong>No</strong>rth Audubon Road, Indianapolis, IN<br />
46<strong>21</strong>9 (US).<br />
(74) DEMETER, John, C. et al. / etc.; Eli Lilly<br />
and Company, Lilly Corporate Center, Indianapolis,<br />
IN 46285 (US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CR CU CZ DE DK DM<br />
DZ EE ES FI GB GD GE GH GM HR HU<br />
ID IL IN IS JP KE KG KP KR KZ LC LK<br />
LR LS LT LU LV MA MD MG MK MN MW<br />
MX MZ NO NZ PL PT RO RU SD SE SG SI<br />
SK SL TJ TM TR TT TZ UA UG US UZ VN<br />
YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GW ML MR<br />
NE SN TD TG).